Terry K. Means
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Terry K. Means has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Andrew D. Luster
Center for Immunology and Inflammatory Diseases and Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129
2 shared publicationsAl Nat
General Hospital Harvard Medical School Charlestown Mass
1 shared publication- Alejandro Aballay
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA
1 shared publication Cameron R. Stewart
Division of Infectious Diseases and 3Lipid Metabolism Unit, Massachusetts General Hospital, Boston, MA 02114
1 shared publicationEdward Seung
Center for Immunology and Inflammatory Diseases and Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129
1 shared publicationEleftherios Mylonakis
Division of Infectious Diseases and 3Lipid Metabolism Unit, Massachusetts General Hospital, Boston, MA 02114
1 shared publication
Latest Publications
- 1 August 2013
- Published by Springer Nature in Science-Business eXchange
- Vol. 6 (32) , 874
Scavenger receptor class F member 1 ( Scarf1 )-deficient mouse model of systemic lupus erythematosus (SLE)
- 1 August 2013
- Published by Springer Nature in Science-Business eXchange
- Vol. 6 (32) , 874
Scavenger receptor class F member 1 ( Scarf1 )-deficient mouse model of systemic lupus erythematosus (SLE)
- Open Access
- 17 December 2010
- Published by Springer Nature in EMBO Reports
- Vol. 12 (1) , 5-7
Models to study ancient host–pathogen interactions: lessons from Crete
The Aegean Conferences' first International Conference on Model Hosts took place on the picturesque Greek island of Crete. This meeting was the first of its kind and gathered together international experts who are using a vast array of hosts as models of infection, including worms, insects, mice, fish, rats, humans, squids, pigs, monkeys, protozoa, amoebae and ticks.
- 17 December 2010
- Published by Springer Nature in EMBO Reports
- Vol. 12 (1) , 5-7
Open AccessModels to study ancient host–pathogen interactions: lessons from Crete
The Aegean Conferences' first International Conference on Model Hosts took place on the picturesque Greek island of Crete. This meeting was the first of its kind and gathered together international experts who are using a vast array of hosts as models of infection, including worms, insects, mice, fish, rats, humans, squids, pigs, monkeys, protozoa, amoebae and ticks.
- Open Access
- 23 February 2009
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 206 (3) , 637-653
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36
Receptors involved in innate immunity to fungal pathogens have not been fully elucidated. We show that the Caenorhabditis elegans receptors CED-1 and C03F11.3, and their mammalian orthologues, the scavenger receptors SCARF1 and CD36, mediate host defense against two prototypic fungal pathogens, Cryptococcus neoformans and Candida albicans. CED-1 and C03F11.1 mediated antimicrobial peptide production and were necessary for nematode survival after C. neoformans infection. SCARF1 and CD36 mediated cytokine production and were required for macrophage binding to C. neoformans, and control of the infection in mice. Binding of these pathogens to SCARF1 and CD36 was β-glucan dependent. Thus, CED-1/SCARF1 and C03F11.3/CD36 are β-glucan binding receptors and define an evolutionarily conserved pathway for the innate sensing of fungal pathogens.
- 23 February 2009
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 206 (3) , 637-653
Open AccessEvolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36
Receptors involved in innate immunity to fungal pathogens have not been fully elucidated. We show that the Caenorhabditis elegans receptors CED-1 and C03F11.3, and their mammalian orthologues, the scavenger receptors SCARF1 and CD36, mediate host defense against two prototypic fungal pathogens, Cryptococcus neoformans and Candida albicans. CED-1 and C03F11.1 mediated antimicrobial peptide production and were necessary for nematode survival after C. neoformans infection. SCARF1 and CD36 mediated cytokine production and were required for macrophage binding to C. neoformans, and control of the infection in mice. Binding of these pathogens to SCARF1 and CD36 was β-glucan dependent. Thus, CED-1/SCARF1 and C03F11.3/CD36 are β-glucan binding receptors and define an evolutionarily conserved pathway for the innate sensing of fungal pathogens.
- 1 December 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1062 (1) , 242-251
Toll‐Like Receptor Activation in the Pathogenesis of Systemic Lupus Erythematosus
Abstract: Systemic lupus erythematosus (SLE) is characterized by the production of pathogenic autoantibodies to nucleoproteins and DNA. The level of anti‐DNA antibodies correlates with disease severity, and the deposition of these immune complexes (ICs) in the kidneys is thought to contribute to disease pathogenesis. Recent evidence suggests that the DNA component of ICs purified from SLE patients (SLE DNA‐ICs) contributes to the development of SLE pathology. SLE DNA‐ICs induce proliferation of self‐reactive B cells and cytokine production by plasmacytoid dendritic cells (PDCs) in a TLR9‐dependent manner. One of the cytokines induced by DNA‐containing ICs is interferon α (IFN‐α). Elevated serum levels of IFN‐α and overexpression of interferon‐induced genes have been observed in SLE patient blood and shown to correlate with disease severity. We have recently found that the mechanism of IFN‐α production by PDCs depends on TLR9 and FcγRIIa (CD32), and CD32 delivers SLE DNA‐ICs to intracellular lysosomes containing TLR9. This CD32‐TLR9 pathway, which is operative in PDCs, is distinct from the BCR/TLR9 pathway in B cells and may prove to be a novel target for future SLE therapies. In this article, the role of toll‐like receptors, cytokines, and Fc receptors expressed by PDCs in the pathogenesis of SLE is summarized.
- 1 December 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1062 (1) , 242-251
Toll‐Like Receptor Activation in the Pathogenesis of Systemic Lupus Erythematosus
Abstract: Systemic lupus erythematosus (SLE) is characterized by the production of pathogenic autoantibodies to nucleoproteins and DNA. The level of anti‐DNA antibodies correlates with disease severity, and the deposition of these immune complexes (ICs) in the kidneys is thought to contribute to disease pathogenesis. Recent evidence suggests that the DNA component of ICs purified from SLE patients (SLE DNA‐ICs) contributes to the development of SLE pathology. SLE DNA‐ICs induce proliferation of self‐reactive B cells and cytokine production by plasmacytoid dendritic cells (PDCs) in a TLR9‐dependent manner. One of the cytokines induced by DNA‐containing ICs is interferon α (IFN‐α). Elevated serum levels of IFN‐α and overexpression of interferon‐induced genes have been observed in SLE patient blood and shown to correlate with disease severity. We have recently found that the mechanism of IFN‐α production by PDCs depends on TLR9 and FcγRIIa (CD32), and CD32 delivers SLE DNA‐ICs to intracellular lysosomes containing TLR9. This CD32‐TLR9 pathway, which is operative in PDCs, is distinct from the BCR/TLR9 pathway in B cells and may prove to be a novel target for future SLE therapies. In this article, the role of toll‐like receptors, cytokines, and Fc receptors expressed by PDCs in the pathogenesis of SLE is summarized.